Peptides: what are they, why are they trending, and are they actually legal?
The term “peptides” has become a buzzword in weight-loss circles, “biohacking” communities, skincare, and sports performance. Whilst some peptide medicines are genuinely transformative, other peptide-based products are experimental compounds being sold online without regulation. Many of these sources are misleading at best and, at worst, dangerous.
This article breaks down:
what peptides are
where they come from
the latest clinically relevant peptide therapies that you might have read about
common uses and side effects,
the legality of peptide use in the UK
What are peptides?
Peptides are an umbrella term for short chains of amino acids (the building blocks of proteins).
Whilst peptides and proteins both share the same constituent pieces, they differ in that peptides are shorter and linear chains whereas proteins are made up of more amino acids (generally more than 100), and they have a 3D structure to get them a specific shape.
Your body naturally produces thousands of peptides that act as signals that switch processes on and off across the brain, gut, immune system, skin, and endocrine (hormone) networks.
Think of them as biological text messages; short, specific, and designed to trigger a response.
In medicine, peptide-based drugs often mimic (or modify) naturally occurring peptides to influence things like:
appetite and satiety
insulin secretion and blood sugar regulation
inflammation and healing pathways
growth hormone signalling
reproductive/sexual function
skin repair and collagen signalling
Where do peptide medicines come from?
Peptides that are used in modern therapeutics generally fall into a few origins:
1) Endogenous peptides → Many peptide drugs are based on hormones we already make. These can then be refined to be longer-lasting or more targeted.
2) Synthetic peptides → Medicinal chemists can build peptides in the lab. A major leap in this field came from solid-phase peptide synthesis, a method that made peptide manufacturing far more scalable and reliable—so impactful it earned a Nobel Prize in Chemistry.
3) Recombinant (biotech-produced) peptides → Some peptide drugs are made using genetically engineered cells (like yeast) that produce the peptide. For example, UK prescribing information for semaglutide (Wegovy) describes it as a GLP-1 analogue produced in yeast cells via recombinant DNA technology.
4) Venoms, microbes, and nature (these can then be lab-engineered later) → A number of modern peptide medicines trace their inspiration to naturally occurring molecules, then get engineered into safe, effective medicines. For example, GLP-1 agonists were originally derived from exendin-4, a compound found in the venom of the Gila monster.
Peptides in clinical practice: the ones with real evidence
Peptides have become a mainstream topic mainly due to the GLP-1 agonists and other incretin-like peptides as they can meaningfully affect:
appetite and cravings
satiety and portion size
blood sugar regulation
cardiometabolic risk (in appropriate patients)
In the UK, these are prescription medicines with defined indications and safety monitoring.
For example:
Semaglutide (Wegovy/Ozempic) – a GLP-1 analogue used for weight management (Wegovy) and diabetes (Ozempic).
Tirzepatide (Mounjaro) – a dual GLP-1/GIP receptor agonist authorised in the UK for weight management under specific criteria.
“Latest” and emerging peptides you’ll hear about
The peptide pipeline is moving fast. A few names currently generating attention:
1) Retatrutide (triple agonist: GIP/GLP-1/glucagon) → an investigational triple-hormone receptor agonist studied for obesity and metabolic disease. Results published in a major medical journal reported substantial weight loss in adults with obesity over 48 weeks. Retatrutide is not approved for use by the MHRA meaning you cannot legally obtain it in the UK. Online claims of “retatrutide for sale” commonly sit in a grey/illegal market where factors such as purity, dosing, and authenticity can’t be trusted.
2) CagriSema (cagrilintide + semaglutide combination) → an investigational combination therapy (amylin analogue + GLP-1 analogue) being studied in late-stage programmes. Recent company and industry reporting has highlighted ongoing Phase 3 development and regulatory momentum. This product is also not something to buy “as a peptide” from a website.
The “wellness peptide” trend: where evidence is often lacking
Alongside legitimate medicines, there’s a surge in peptides marketed for:
injury healing / tendon repair
muscle growth or “recomp”
longevity
cognitive enhancement
libido / sexual performance
skin quality and hair growth
Some of these compounds are research-only with limited human data—or none. Two widely promoted examples are:
BPC-157 which is often marketed for gut health or injury healing. Anti-doping authorities categorise it as a prohibited, unapproved substance; it’s not approved for human clinical use by major regulators.
TB-500 (thymosin beta-4 fragment) is similarly promoted online for repair and recovery, but commonly discussed in the context of limited evidence and regulatory non-approval in the UK.
The biggest risks with these types of products aren’t theoretical:
uncertain identity (you may not be getting what you think)
unregulated manufacturing conditions can lead to contamination, endotoxins, and sterility failures
dosing errors
the lack of evidence or monitoring for interactions/contraindications can lead to unexpected side effects or immunologic reactions (especially prevalent with injectables)
Legality in the UK: what’s actually allowed?
Here’s the practical, patient-relevant view:
1) Licensed medicines → If a peptide is an MHRA-authorised medicine (e.g., Wegovy, Mounjaro), it can be prescribed and supplied through appropriate regulated channels.
2) Unlicensed medicines (“specials”) → The UK does allow supply of unlicensed medicines in tightly controlled circumstances (often called “specials”), generally for an individual patient following a prescription and supply through regulated routes (eg. a registered pharmacy).
3) Research peptides sold online → Many websites attempt to bypass regulation by labelling vials “for research use only” while clearly implying human use. In the UK, marketing or supplying medicinal products for human use outside the regulatory framework can put sellers (and patients) at risk. This is because these products are unlicensed, sometimes counterfeit, and supplied without appropriate clinical oversight.
So the bottom line for those living in the UK)
If it’s not a licensed medicine (or a legitimate unlicensed “special” supplied appropriately), assume it is not legal to purchase for self-use.
Even when something exists in clinical trials, that does not make it legal or safe to buy.
This article has highlighted that “Grey market” injectables carry an increased health risk but has not really explained why this is the case. As with any injectable, commonly reported side-effects include local reaction at injection site, headaches, gastro-intestinal upset, vasovagal reactions.
But more of concern are issues pertaining to sterility and purity of the product and supply chain, handling and storage of the product, mislabelling, contamination and unknown pharmacology at real-world doses. Licensed medications undergo post-market surveillance to ensure their ongoing safety and efficacy in a larger population.
How Orion Medica considers peptides
From a clinician-led, outcomes-focused perspective:
The most meaningful peptide innovations in weight and metabolic health are prescription-only (eg. GLP-1 agonists) - used within clear criteria, with monitoring.
Experimental “research peptides” are not a substitute for regulated care, especially when sourced online. The biggest risks often come from the supply chain - not just the molecule.
Legality and quality control matter. A medicine’s evidence base is inseparable from how safely and consistently it can be made, prescribed, and monitored.
Medical note (important): This article is educational and not a substitute for personalised medical advice. If you’re considering any prescription medicine (including GLP-1 medications), speak to a qualified clinician.
